Comerica Securities’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-2,295
Closed -$266K 408
2018
Q3
$266K Sell
2,295
-2,374
-51% -$268K 0.03% 368
2018
Q2
$589K Buy
4,669
+529
+13% +$64.4K 0.07% 246
2018
Q1
$448K Buy
4,140
+642
+18% +$71K 0.06% 280
2017
Q4
$383K Buy
3,498
+277
+9% +$27.6K 0.05% 300
2017
Q3
$318K Buy
3,221
+461
+17% +$44.7K 0.04% 314
2017
Q2
$280K Buy
2,760
+231
+9% +$24.9K 0.04% 328
2017
Q1
$292K Buy
2,529
+465
+23% +$54K 0.05% 315
2016
Q4
$248K Hold
2,064
0.06% 309
2016
Q3
$232K Sell
2,064
-12
-0.6% -$1.38K 0.05% 307
2016
Q2
$257K Buy
2,076
+200
+11% +$24.1K 0.05% 297
2016
Q1
$211K Buy
+1,876
New +$195K 0.05% 322
2015
Q1
Sell
-1,756
Closed -$212K 307
2014
Q4
$212K Buy
+1,756
New +$231K 0.07% 269

Other funds holding CLB

Comerica Securities's CLB Position: Q4 2018 in Review

Comerica Securities sold out of Core Laboratories (CLB) in Q4 2018, closing a stake of 2,295 shares — an estimated $266K sold.

Comerica Securities first reported a position in CLB in Q4 2014 and held it in 12 quarters. The position peaked at $589K in Q2 2018. 320 funds tracked by Wall St. Rank hold CLB as of Q4 2018.

  • Comerica Securities reported no remaining Core Laboratories position as of Q4 2018 after selling out during the quarter.
  • Comerica Securities sold 2,295 Core Laboratories shares in Q4 2018, an estimated $266K.
  • Comerica Securities first reported a position in Core Laboratories in Q4 2014 and held it in 12 quarters.
  • Comerica Securities's Core Laboratories position peaked at $589K in Q2 2018.
  • 320 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2018.

Based on Comerica Securities's 13F filing for Q4 2018, filed 5 Feb 2019.